Search results
Reports of Surprise Pregnancies While Taking Ozempic Are Surfacing—What to Know
Prevention via Yahoo News· 6 days agoReports of “Ozempic babies” are surfacing. Doctors explain why some are experiencing surprise...
Trendy SF wellness company unveils cheap copycat of Ozempic
San Francisco Chronicle· 1 day agoHims & Hers Health has grown into a telehealth giant by making it easier to order generic versions...
Is Novo Nordisk Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 4 days agoPeople who are overweight or who have diabetes often have other healthcare issues as well. By...it has shown that it can also help people reduce their...
High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Treatment
North Denver News· 22 hours agoHarris and her husband, Marcus, who both have diabetes, have struggled to fill their prescriptions...
2 Top Growth Stocks Down 24% and 50% to Buy With $100
Motley Fool via Yahoo Finance· 6 days agoLast year, Pfizer had more products approved by the U.S. Food and Drug Administration than any other...
Weight Loss Drug Can Sustain Results For Up To 4 Years And May Protect Hearts Too
IFLScience· 5 days agoWegovy, an injectable prescription weight loss drug, can produce effective results that help patients keep weight off for up to four years, a new study suggests. The
What happened when TikTok said users can’t promote weight-loss drugs
Washington Post via Yahoo Finance· 2 days agoTaylor Hubler went to pull up TikTok on her phone one day last month and saw she was logged out....
If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have Today | The...
The Motley Fool· 7 days agoIt's a good bet that, five years ago, the average American investor would not have been familiar...
Hims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To Wegovy
Forbes· 2 days agoShares of telehealth company Hims & Hers Health closed at a three-year high Monday after the company...
If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have Today
The Motley Fool via AOL· 7 days agoThat's because the Denmark-based company had not yet won U.S. Food and Drug Administration (FDA) approval for its ...